(UroToday.com) Most patients newly diagnosed with bladder cancer have non-muscle invasive disease (NMIBC). For patients with intermediate or high-risk NMIBC and those with carcinoma in situ (CIS), ...
Daniel Spratt and Alicia Morgans discuss clinical outcomes of patients with Gleason score 9-10 prostate cancer after definitive treatment. Long-term Survival in Men with Gleason Score 9-10 Treated ...
Oliver Sartor, M.D., Johann de Bono, M.B., Ch.B., Ph.D., Kim N. Chi, M.D., Karim Fizazi, M.D., Ph.D., Ken Herrmann, M.D., Kambiz Rahbar, M.D., Scott T. Tagawa, M.D ...
It is with great pleasure that I welcome all of you to the Urotoday Center of Excellence on Functional Urology. My goal is to highlight current topics of interest by citing selected and specific ...
(UroToday.com) The 2025 Society of Urologic Oncology (SUO) Annual Meeting was host to a bladder cancer poster session. Dr. Ahmed Eraky presented a study demonstrating that pre-cystectomy ctDNA burden ...
The cell-surface glycoprotein TROP2 (also called TACSTD2) is increasingly recognized as a potential therapeutic target in advanced prostate cancer, owing to its membrane localization, maintained ...
Genomic characterization of metastatic prostate cancer (mPCa) plays a pivotal role in guiding precision oncology. This study aimed to evaluate the feasibility of combining radiomics and clinical data ...
With rising surgical wait times for benign prostatic hyperplasia (BPH)-related urinary retention (UR), we aimed to assess the healthcare costs of prolonged UR management in patients awaiting holmium ...
Locally advanced penile squamous cell carcinoma (PSCC) generally has a poor prognosis. Our aim was to access the efficacy and safety of programmed cell death protein 1 (PD-1) inhibitor tislelizumab ...
Men with Grade Group (GG) 1-2 prostate cancer (PCa) are generally candidates for active surveillance, yet the presence of a PI-RADS 5 lesion on mpMRI often prompts definitive treatment. Data on ...
(UroToday.com) The 2025 SUO annual meeting featured a urothelial carcinoma session and a presentation by Dr. Reuben Ben-David discussing preoperative ctDNA predicting upstaging and recurrence in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results